01 Drug Discovery

Multi-pronged approach to identify top-tier hits

02
AI Powered Virtual Screening

Expanding chemical space with AI precision

Begin your drug discovery campaign with an in silico platform that searches a broader chemical space quickly and accurately.

2 Million accessible building blocks to expand the chemical space to 10^12 library compounds
Successfully identified hit compounds for 95% of projects
57 out of 60 completed
AI and physics-based computation methods
03
High-Throughput Screening

AI & automation for efficient drug screening

Hone in on the most viable drug candidates with an extremely comprehensive screening process.

200K+ drug-like screening compounds for purchase or in-house screening
7.8M+ compounds synthesizable by automated click chemistry
AI-driven automated platform for effective screening and data analysis
Off-the-shelf or bespoke development of robust bioassays for diverse therapeutic areas
04
AI & Automation Powered DNA Encoded Libraries

DEL screening & hit validation high-accuracy

Accelerate discovery with vast diversity and precision screening
Massive Library Size
Enables simultaneous screening of billions of compounds, increasing the chances of finding novel hits
Minimal Protein and Assay Requirements Requires minimal target protein and assay development, making highly efficient and accessible for early-stage drug discovey
Reduced Cost with Maximized Efficiency Combines DEL screening with proprietary virtual screening to ease the burden of off-DNA synthesis and yield more reliable results

Your next success starts here

Harness the power of AI & Automation to discover new life-changing drugs, faster and more efficiently.

Search XtalPi

Development of small molecule selective inhibitors with XFEP
Discovery of Novel Non-covalent GPX4 Potent Hits with XFEP
Discovery of Novel Leads Targeting a Highly Flexible Allosteric Site with XMolGen and XFEP